Carregant...
Anti-adalimumab antibodies in psoriasis: lack of clinical utility and laboratory evidence
OBJECTIVE: Adalimumab has proven effective in psoriasis; however, secondary failure may result from the drug's immunogenicity. Prevalence data on the immunogenicity of biologicals, and of adalimumab in particular, are highly variable. We investigated the prevalence of anti-adalimumab antibodies...
Guardat en:
| Publicat a: | BMJ Open |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5168630/ https://ncbi.nlm.nih.gov/pubmed/27940624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-011941 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|